National Human Genome Research Institute; Notice of Meeting, 65204 [2011-27178]
Download as PDF
65204
Federal Register / Vol. 76, No. 203 / Thursday, October 20, 2011 / Notices
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group, AIDS
Immunology and Pathogenesis Study
Section.
Date: November 21, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Academic
Research Enhancement AREA Grant
Applications.
Date: November 21–22, 2011.
Date: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Elena Smirnova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–435–
1236, smirnove@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27224 Filed 10–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSK5SPTVN1PROD with NOTICES
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Human Genome Research Institute.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Mar<15>2010
18:59 Oct 19, 2011
Jkt 226001
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Human Genome Research
Institute, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: November 14–16, 2011.
Open: November 14, 2011, 5:45 p.m. to
7:30 p.m.
Agenda: Updates from the Director and
Scientific Director.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Salon II, Rockville, MD
20852.
Closed: November 14, 2011, 7:30 p.m. to 11
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Closed: November 15, 2011, 8 a.m. to 6
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, Bethesda, MD
20892.
Closed: November 16, 2011, 8 a.m. to 3:30
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, Bethesda, MD
20892.
Contact Person: Claire Kelso, Intramural
Program Specialist, Division of Intramural
Research, Office of the Scientific Director,
National Human Genome Research Institute,
50 South Drive, Building 50, Room 5222,
Bethesda, MD 20892–8002. 301 435–5802.
claire@nhgri.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: October 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27178 Filed 10–19–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group, Acquired Immunodeficiency
Syndrome Research Review Committee.
Date: November 15, 2011.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Sujata Vijh, PhD, Scientific
Review Officer, Scientific Review Program,
DEA/NIAID/NIH, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
594–0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27241 Filed 10–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\20OCN1.SGM
20OCN1
Agencies
[Federal Register Volume 76, Number 203 (Thursday, October 20, 2011)]
[Notices]
[Page 65204]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Human Genome Research
Institute.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Human Genome Research Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Human Genome Research Institute.
Date: November 14-16, 2011.
Open: November 14, 2011, 5:45 p.m. to 7:30 p.m.
Agenda: Updates from the Director and Scientific Director.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Salon II, Rockville, MD 20852.
Closed: November 14, 2011, 7:30 p.m. to 11 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Closed: November 15, 2011, 8 a.m. to 6 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Human Genome Research Institute, 5635 Fishers
Lane, Bethesda, MD 20892.
Closed: November 16, 2011, 8 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Human Genome Research Institute, 5635 Fishers
Lane, Bethesda, MD 20892.
Contact Person: Claire Kelso, Intramural Program Specialist,
Division of Intramural Research, Office of the Scientific Director,
National Human Genome Research Institute, 50 South Drive, Building
50, Room 5222, Bethesda, MD 20892-8002. 301 435-5802.
claire@nhgri.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: October 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-27178 Filed 10-19-11; 8:45 am]
BILLING CODE 4140-01-P